Boryung Pharm’s ‘Kanarb Tab’ recording highest manufacturing performance last year among Korean new drugs

Published: 2017-07-10 16:29:00
Updated: 2017-07-10 14:51:15

Among pharmaceutical products approved as new drug developed in Korea, a product which recorded the highest sales was ‘Kanarb Tab,’ a Boryung Pharm’s antihypertensive.

In addition, among the 26 new drugs developed in Korea, there were only 5 products with a manufacturing performance more than KR...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.